Author

Connie S. Schmaljohn

National Institute of Allergy and Infectious DiseasesORCID 0000-0001-8852-5482Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Connie S. Schmaljohn1 paper

Biology Disciplines

Click to filter author papers

Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Agnes Bugajska-SchretteriD· 1 shared Alexander Michael DohnaliD· 1 shared Alì MirazimiiD· 1 shared Alice Schwarzböck· 1 shared Anna Sanchez JimeneziD· 1 shared Astrid HagelkrüysiD· 1 shared Benedict BraunsfeldiD· 1 shared Brett EatoniD· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Agnes Bugajska-SchretterORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Molecular BiologyEMBO Molecular MedicinePeer-reviewedJul 4, 2022

Clinical grade ACE2 as a universal agent to block SARS-CoV-2 variants

Vanessa Monteil, Brett Eaton, Elena N. Postnikova…·Josef Martin Penninger

This paper shows that clinical-grade soluble ACE2 effectively inhibits multiple SARS-CoV-2 variants, including VOCs, in cell cultures and across independent labs.

59 citationstop 2%

humanexperimental assay

𝕏 PostBluesky